Product Code: ETC13235431 | Publication Date: Apr 2025 | Updated Date: Jul 2025 | Product Type: Market Research Report | |
Publisher: 6Wresearch | Author: Ravi Bhandari | No. of Pages: 190 | No. of Figures: 80 | No. of Tables: 40 |
According to 6Wresearch internal database and industry insights, the Global Acute Bacterial Skin & Skin Structure Infection Market was valued at USD 4.2 Billion in 2024 and is expected to reach USD 8.9 Billion by 2031, growing at a compound annual growth rate of 13.20% during the forecast period (2025-2031).
The Global Acute Bacterial Skin & Skin Structure Infection (ABSSSI) Market is witnessing steady growth due to the increasing prevalence of skin infections worldwide. Factors such as a rise in bacterial resistance, changing lifestyles, and higher awareness about skin health are driving market growth. The market is characterized by the presence of key players offering a variety of treatment options including antibiotics, surgical interventions, and wound care products. Additionally, advancements in medical technology and the development of novel therapies are further boosting market expansion. Geographically, North America holds a significant share in the market, followed by Europe and Asia-Pacific regions. With ongoing research and development activities focused on improving treatment outcomes for ABSSSI, the market is expected to continue its growth trajectory in the coming years.
The Global Acute Bacterial Skin & Skin Structure Infection Market is experiencing growth driven by the increasing incidence of skin infections, rising awareness about proper hygiene practices, and the development of novel treatment options. The market is witnessing a shift towards the use of advanced antibiotics, such as lipoglycopeptides and cephalosporins, to combat antibiotic-resistant strains of bacteria. Additionally, the growing geriatric population and higher healthcare expenditure in developing countries present lucrative opportunities for market expansion. Telemedicine and digital health solutions are also emerging as key trends in the market, enabling remote consultations and monitoring of skin infections. Overall, the market is poised for steady growth with a focus on innovation, patient-centric care, and strategic collaborations between pharmaceutical companies and healthcare providers.
The Global Acute Bacterial Skin & Skin Structure Infection Market faces several challenges, including increasing antibiotic resistance among bacterial strains, which limits the effectiveness of current treatment options. Additionally, the complexity of diagnosing skin infections accurately can lead to misdiagnosis and inappropriate treatment. Regulatory hurdles in drug approval processes and the high cost of research and development for new antibiotics further hinder market growth. Market fragmentation and competition among existing treatment options also pose challenges in establishing a strong market presence for newer therapies. Overall, addressing these challenges requires a multi-faceted approach that includes innovative research and development strategies, enhanced diagnostic capabilities, and collaboration among healthcare professionals, pharmaceutical companies, and regulatory bodies.
The global Acute Bacterial Skin & Skin Structure Infection (ABSSSI) market is primarily driven by factors such as the increasing prevalence of skin infections, growing awareness about appropriate treatment options, and the development of novel antibiotics targeting resistant bacterial strains. The rising incidence of ABSSSI due to factors like diabetes, compromised immune systems, and surgical wounds is also fueling market growth. Additionally, the focus on reducing healthcare costs and hospital stays by adopting effective treatment strategies for skin infections is driving the demand for advanced therapies and treatment options. The emergence of biotechnology companies and pharmaceutical firms investing in research and development activities to introduce innovative therapies further contributes to the expansion of the ABSSSI market on a global scale.
Government policies related to the Global Acute Bacterial Skin & Skin Structure Infection (ABSSSI) Market primarily focus on promoting antibiotic stewardship to combat the rise of antibiotic-resistant bacteria. Initiatives include regulations on antibiotic use, surveillance programs to monitor antibiotic resistance trends, and funding for research into new antibiotics and alternative treatments. Additionally, government agencies may provide incentives such as grants, tax credits, or expedited regulatory pathways to encourage the development of new therapies for ABSSSI. Some countries also implement guidelines for the appropriate management of ABSSSI cases to optimize patient outcomes and minimize healthcare costs. Overall, government policies strive to address the public health threat posed by antibiotic resistance while supporting innovation in the treatment of ABSSSI.
The Global Acute Bacterial Skin & Skin Structure Infection (ABSSSI) market is expected to witness steady growth in the coming years due to factors such as the increasing prevalence of skin infections, rising awareness about appropriate treatment options, and advancements in medical technology. The market is projected to be driven by the introduction of novel antibiotics, expanding patient pool, and the growing demand for effective and safe treatment solutions. Additionally, the rise in healthcare expenditure, improving access to healthcare facilities in developing regions, and the focus on research and development activities by key players are anticipated to further propel market growth. However, factors such as the emergence of antibiotic resistance and stringent regulatory requirements may pose challenges to market expansion. Overall, the Global ABSSSI market is forecasted to experience significant growth opportunities in the foreseeable future.
In the Global Acute Bacterial Skin & Skin Structure Infection market, Asia is expected to witness significant growth due to the rising prevalence of skin infections and improving healthcare infrastructure. North America is projected to dominate the market owing to high healthcare expenditure and advanced medical facilities. In Europe, the market is driven by the increasing awareness about skin infections and the presence of key market players. The Middle East and Africa region is anticipated to show steady growth due to improving access to healthcare services. Latin America is also poised for growth due to the increasing focus on infectious disease management and the rising healthcare investments in the region. Overall, the global market for Acute Bacterial Skin & Skin Structure Infection is expected to witness substantial growth across all regions driven by factors such as increasing incidence of skin infections and advancements in treatment options.
Global Acute Bacterial Skin & Skin Structure Infection Market |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Global Acute Bacterial Skin & Skin Structure Infection Market Overview |
3.1 Global Regional Macro Economic Indicators |
3.2 Global Acute Bacterial Skin & Skin Structure Infection Market Revenues & Volume, 2021 & 2031F |
3.3 Global Acute Bacterial Skin & Skin Structure Infection Market - Industry Life Cycle |
3.4 Global Acute Bacterial Skin & Skin Structure Infection Market - Porter's Five Forces |
3.5 Global Acute Bacterial Skin & Skin Structure Infection Market Revenues & Volume Share, By Regions, 2021 & 2031F |
3.6 Global Acute Bacterial Skin & Skin Structure Infection Market Revenues & Volume Share, By Typeof Infection, 2021 & 2031F |
3.7 Global Acute Bacterial Skin & Skin Structure Infection Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.8 Global Acute Bacterial Skin & Skin Structure Infection Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Global Acute Bacterial Skin & Skin Structure Infection Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Global Acute Bacterial Skin & Skin Structure Infection Market Trends |
6 Global Acute Bacterial Skin & Skin Structure Infection Market, 2021 - 2031 |
6.1 Global Acute Bacterial Skin & Skin Structure Infection Market, Revenues & Volume, By Typeof Infection, 2021 - 2031 |
6.1.1 Overview & Analysis |
6.1.2 Global Acute Bacterial Skin & Skin Structure Infection Market, Revenues & Volume, By Hospital-acquired ABSSI, 2021 - 2031 |
6.1.3 Global Acute Bacterial Skin & Skin Structure Infection Market, Revenues & Volume, By Community-acquired ABSSI, 2021 - 2031 |
6.2 Global Acute Bacterial Skin & Skin Structure Infection Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
6.2.1 Overview & Analysis |
6.2.2 Global Acute Bacterial Skin & Skin Structure Infection Market, Revenues & Volume, By Oral, 2021 - 2031 |
6.2.3 Global Acute Bacterial Skin & Skin Structure Infection Market, Revenues & Volume, By Parenteral, 2021 - 2031 |
6.3 Global Acute Bacterial Skin & Skin Structure Infection Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
6.3.1 Overview & Analysis |
6.3.2 Global Acute Bacterial Skin & Skin Structure Infection Market, Revenues & Volume, By Hospital Pharmacies, 2021 - 2031 |
6.3.3 Global Acute Bacterial Skin & Skin Structure Infection Market, Revenues & Volume, By Retail Pharmacies, 2021 - 2031 |
6.3.4 Global Acute Bacterial Skin & Skin Structure Infection Market, Revenues & Volume, By Online Pharmacies, 2021 - 2031 |
7 North America Acute Bacterial Skin & Skin Structure Infection Market, Overview & Analysis |
7.1 North America Acute Bacterial Skin & Skin Structure Infection Market Revenues & Volume, 2021 - 2031 |
7.2 North America Acute Bacterial Skin & Skin Structure Infection Market, Revenues & Volume, By Countries, 2021 - 2031 |
7.2.1 United States (US) Acute Bacterial Skin & Skin Structure Infection Market, Revenues & Volume, 2021 - 2031 |
7.2.2 Canada Acute Bacterial Skin & Skin Structure Infection Market, Revenues & Volume, 2021 - 2031 |
7.2.3 Rest of North America Acute Bacterial Skin & Skin Structure Infection Market, Revenues & Volume, 2021 - 2031 |
7.3 North America Acute Bacterial Skin & Skin Structure Infection Market, Revenues & Volume, By Typeof Infection, 2021 - 2031 |
7.4 North America Acute Bacterial Skin & Skin Structure Infection Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
7.5 North America Acute Bacterial Skin & Skin Structure Infection Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
8 Latin America (LATAM) Acute Bacterial Skin & Skin Structure Infection Market, Overview & Analysis |
8.1 Latin America (LATAM) Acute Bacterial Skin & Skin Structure Infection Market Revenues & Volume, 2021 - 2031 |
8.2 Latin America (LATAM) Acute Bacterial Skin & Skin Structure Infection Market, Revenues & Volume, By Countries, 2021 - 2031 |
8.2.1 Brazil Acute Bacterial Skin & Skin Structure Infection Market, Revenues & Volume, 2021 - 2031 |
8.2.2 Mexico Acute Bacterial Skin & Skin Structure Infection Market, Revenues & Volume, 2021 - 2031 |
8.2.3 Argentina Acute Bacterial Skin & Skin Structure Infection Market, Revenues & Volume, 2021 - 2031 |
8.2.4 Rest of LATAM Acute Bacterial Skin & Skin Structure Infection Market, Revenues & Volume, 2021 - 2031 |
8.3 Latin America (LATAM) Acute Bacterial Skin & Skin Structure Infection Market, Revenues & Volume, By Typeof Infection, 2021 - 2031 |
8.4 Latin America (LATAM) Acute Bacterial Skin & Skin Structure Infection Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
8.5 Latin America (LATAM) Acute Bacterial Skin & Skin Structure Infection Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
9 Asia Acute Bacterial Skin & Skin Structure Infection Market, Overview & Analysis |
9.1 Asia Acute Bacterial Skin & Skin Structure Infection Market Revenues & Volume, 2021 - 2031 |
9.2 Asia Acute Bacterial Skin & Skin Structure Infection Market, Revenues & Volume, By Countries, 2021 - 2031 |
9.2.1 India Acute Bacterial Skin & Skin Structure Infection Market, Revenues & Volume, 2021 - 2031 |
9.2.2 China Acute Bacterial Skin & Skin Structure Infection Market, Revenues & Volume, 2021 - 2031 |
9.2.3 Japan Acute Bacterial Skin & Skin Structure Infection Market, Revenues & Volume, 2021 - 2031 |
9.2.4 Rest of Asia Acute Bacterial Skin & Skin Structure Infection Market, Revenues & Volume, 2021 - 2031 |
9.3 Asia Acute Bacterial Skin & Skin Structure Infection Market, Revenues & Volume, By Typeof Infection, 2021 - 2031 |
9.4 Asia Acute Bacterial Skin & Skin Structure Infection Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
9.5 Asia Acute Bacterial Skin & Skin Structure Infection Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
10 Africa Acute Bacterial Skin & Skin Structure Infection Market, Overview & Analysis |
10.1 Africa Acute Bacterial Skin & Skin Structure Infection Market Revenues & Volume, 2021 - 2031 |
10.2 Africa Acute Bacterial Skin & Skin Structure Infection Market, Revenues & Volume, By Countries, 2021 - 2031 |
10.2.1 South Africa Acute Bacterial Skin & Skin Structure Infection Market, Revenues & Volume, 2021 - 2031 |
10.2.2 Egypt Acute Bacterial Skin & Skin Structure Infection Market, Revenues & Volume, 2021 - 2031 |
10.2.3 Nigeria Acute Bacterial Skin & Skin Structure Infection Market, Revenues & Volume, 2021 - 2031 |
10.2.4 Rest of Africa Acute Bacterial Skin & Skin Structure Infection Market, Revenues & Volume, 2021 - 2031 |
10.3 Africa Acute Bacterial Skin & Skin Structure Infection Market, Revenues & Volume, By Typeof Infection, 2021 - 2031 |
10.4 Africa Acute Bacterial Skin & Skin Structure Infection Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
10.5 Africa Acute Bacterial Skin & Skin Structure Infection Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
11 Europe Acute Bacterial Skin & Skin Structure Infection Market, Overview & Analysis |
11.1 Europe Acute Bacterial Skin & Skin Structure Infection Market Revenues & Volume, 2021 - 2031 |
11.2 Europe Acute Bacterial Skin & Skin Structure Infection Market, Revenues & Volume, By Countries, 2021 - 2031 |
11.2.1 United Kingdom Acute Bacterial Skin & Skin Structure Infection Market, Revenues & Volume, 2021 - 2031 |
11.2.2 Germany Acute Bacterial Skin & Skin Structure Infection Market, Revenues & Volume, 2021 - 2031 |
11.2.3 France Acute Bacterial Skin & Skin Structure Infection Market, Revenues & Volume, 2021 - 2031 |
11.2.4 Rest of Europe Acute Bacterial Skin & Skin Structure Infection Market, Revenues & Volume, 2021 - 2031 |
11.3 Europe Acute Bacterial Skin & Skin Structure Infection Market, Revenues & Volume, By Typeof Infection, 2021 - 2031 |
11.4 Europe Acute Bacterial Skin & Skin Structure Infection Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
11.5 Europe Acute Bacterial Skin & Skin Structure Infection Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
12 Middle East Acute Bacterial Skin & Skin Structure Infection Market, Overview & Analysis |
12.1 Middle East Acute Bacterial Skin & Skin Structure Infection Market Revenues & Volume, 2021 - 2031 |
12.2 Middle East Acute Bacterial Skin & Skin Structure Infection Market, Revenues & Volume, By Countries, 2021 - 2031 |
12.2.1 Saudi Arabia Acute Bacterial Skin & Skin Structure Infection Market, Revenues & Volume, 2021 - 2031 |
12.2.2 UAE Acute Bacterial Skin & Skin Structure Infection Market, Revenues & Volume, 2021 - 2031 |
12.2.3 Turkey Acute Bacterial Skin & Skin Structure Infection Market, Revenues & Volume, 2021 - 2031 |
12.3 Middle East Acute Bacterial Skin & Skin Structure Infection Market, Revenues & Volume, By Typeof Infection, 2021 - 2031 |
12.4 Middle East Acute Bacterial Skin & Skin Structure Infection Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
12.5 Middle East Acute Bacterial Skin & Skin Structure Infection Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
13 Global Acute Bacterial Skin & Skin Structure Infection Market Key Performance Indicators |
14 Global Acute Bacterial Skin & Skin Structure Infection Market - Export/Import By Countries Assessment |
15 Global Acute Bacterial Skin & Skin Structure Infection Market - Opportunity Assessment |
15.1 Global Acute Bacterial Skin & Skin Structure Infection Market Opportunity Assessment, By Countries, 2021 & 2031F |
15.2 Global Acute Bacterial Skin & Skin Structure Infection Market Opportunity Assessment, By Typeof Infection, 2021 & 2031F |
15.3 Global Acute Bacterial Skin & Skin Structure Infection Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
15.4 Global Acute Bacterial Skin & Skin Structure Infection Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
16 Global Acute Bacterial Skin & Skin Structure Infection Market - Competitive Landscape |
16.1 Global Acute Bacterial Skin & Skin Structure Infection Market Revenue Share, By Companies, 2024 |
16.2 Global Acute Bacterial Skin & Skin Structure Infection Market Competitive Benchmarking, By Operating and Technical Parameters |
17 Top 10 Company Profiles |
18 Recommendations |
19 Disclaimer |